Evidence map›Paper›PMID 23559400›Full record

ArticleNeuroradiology2013

Tissue at risk in acute stroke patients treated beyond 8 h after symptom onset.

C Leiva-Salinas, A Aghaebrahim, G Zhu, J T Patrie, W Xin, B C Lau, T Jovin, M Wintermark

Abstract read
PubMed Publisher
In one paragraph

Article in Neuroradiology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. [From stroke to reperfusion : How can we be faster?]Medizinische Klinik, Intensivmedizin und Notfallmedizin · 2016
    Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

C Leiva-SalinasDepartment of Radiology, Neuroradiology Division, University of Virginia, 1215 Lee Street-New Hospital, 1st Floor, Room 1011, PO Box 800170, Charlottesville, VA 22908, USA.
A Aghaebrahim
G Zhu
J T Patrie
W Xin
B C Lau
T Jovin
M Wintermark
University of Virginia Hospital · USUniversity of Pittsburgh · USUniversity of Virginia · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThe decision on thrombolytics administration is usually based on a generalized, rigid time-based rule rather than an individualized evaluation of the "tissue at risk of infarction" which is the target of the recanalization therapies. The goals of our article are to assess whether there is tissue at risk of infarction in a group of acute stroke patients treated beyond 8 h after symptom onset and to investigate the baseline imaging and clinical features that predict the fate of this tissue at risk.

methodsWe retrospectively reviewed a series of patients with acute ischemic stroke treated with endovascular recanalization therapies beyond 8 h after symptom onset. The tissue at risk was calculated as the difference between the infarct volumes on baseline and follow-up imaging (infarct growth). We analyzed the epidemiological distribution of infarct growth, and we performed a multivariate regression analysis to identify the baseline variables that predict infarct growth.

resultsOur study group included 75 patients (65 ± 13.8 years, baseline National Institutes of Health Stroke Scale 14 ± 4.9, time to treatment 15.2 ± 8.7 h). The mean infarct growth was 78.6 ± 95.0 cc (p < 0.001), and, overall, the infarct growth was greater when the baseline volume of infarct tissue was small (p < 0.001) and in the case of a unsuccessful arterial recanalization (p = 0.001).

conclusionsThere is potentially salvageable ischemic tissue at risk in acute stroke patients treated beyond 8 h after symptom onset.

Indexed as

AdultAgedAged, 80 and overCerebral AngiographyEndovascular ProceduresFemaleFibrinolytic AgentsHumansIncidenceMaleMiddle AgedOrgans at RiskPrognosisReproducibility of ResultsRetrospective StudiesRisk AssessmentFibrinolytic Agents

Identifiers

PMID23559400
OpenAlexW2004965495

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.